Case studies
Filter
-
Case study: The first unconjugated antibody against TROP-2, humanized for KisoJi Biotechnology
Read more: Case study: The first unconjugated antibody against TROP-2, humanized for KisoJi Biotechnology -
LifeArc collaboration helps to advance a potential new cancer drug towards the clinic
Read more: LifeArc collaboration helps to advance a potential new cancer drug towards the clinic -
Exploring new approaches to drug discovery
Read more: Exploring new approaches to drug discovery -
Developing the next generation of technology transfer specialists
Read more: Developing the next generation of technology transfer specialists -
Rising to the challenge of COVID-19
Read more: Rising to the challenge of COVID-19 -
Collaboration leads to promising new approach for Alzheimer’s disease
Read more: Collaboration leads to promising new approach for Alzheimer’s disease -
How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response
Read more: How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response -
LifeArc supports MRC spin-out to Series A funding
Read more: LifeArc supports MRC spin-out to Series A funding -
LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy
Read more: LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy -
Virtual reality technology for small molecular drug discovery
Read more: Virtual reality technology for small molecular drug discovery -
Collaborating to conquer Alzheimer’s disease
Read more: Collaborating to conquer Alzheimer’s disease -
Life, re-engineered: new milestone in the emerging field of synthetic genomics
Read more: Life, re-engineered: new milestone in the emerging field of synthetic genomics